1 Trentham DE, Dynesius-Treatham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, et al. Effects of oral administration of type Ⅱ collagen on rheumatoid arthritis[J]. Science, 1993 ; 261:1727-30 2 Sieper J, Kary S, Srensen H, Alten R, Eggens U, Huge W, et al. Oral type Ⅱ collagen treatment in early rheumatoid arthritis[J]. Arthritis Rheum, 1996;39(1):41-51 3 Snowden N, Re I, Morgan K, Holt L.T cell responses to human type Ⅱ collagen in patients with rheumatoid arthritis and healthy controls[J]. Arthritis Rheum, 1997 ;40(7):1210-8 4 Seyer JM, Hasty KA, Kang AH.Covalent structure of collagen.Amino acid sequence of an arthrilogenic cyanogens bromide peptide from type Ⅱ collagen of bovine cartilage[J]. Eur J Biochem, 1989;181:159-73 5 Krco CJ, Pawelski J, Harders J, McCormick D, Griffiths M, Luthra HS, et al. Characterization of the antigenic structure of human type Ⅱ collagen[J]. J Immun, 1996;156:2761-8 6 Myers LK, Cooper SW, Terato K, Seyer JM, Stuart JM, Kang AH.Identification and characterization of a tolerogenic T cell determinant within residues 181-209 of chick type Ⅱ collagen[J]. Clin Immunol Immunopathol, 1995 ;75(1):33-8 7 陈敏珠, 魏伟, 张泓, 梁君山.免疫抑制药和免疫增强药实验法[A]. 见:徐叔云, 卞如濂, 陈修, 主编.药理实验方法学[M]. 第2 版.北京:人民卫生出版社, 1991:1208-45 8 Masseyeff RF, Albert WH, Staines NA.Methods of Immunological Analysis:Cell and Tissue[M]. Vol.3.New York:Wiley-VCH, 1993:65-6 9 Gitter BD, Labus JM, Lees SL, Scheetz ME.Characteristics of human synovial fibroblast activation by IL-1β and TNF[J]. Immunology, 1989 ;66:196-200 10 Weiner HL, Friedm A, Miller A, Khoury SJ, Al-Sabbagh A, Santos L, et al. Oral tolerance:Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens[J]. Annu Rev Immunol, 1994 ;12:809-37 |